|
WO2021068925A1
|
|
Improved uricase and method for treating hyperuricemia using same
|
|
WO2021008523A1
|
|
Anti-tigit antibodies and application thereof
|
|
CN111821434A
|
|
Use of anti-PD-1 antibody in preparation of medicine for treating solid tumor
|
|
CN111303283A
|
|
anti-IL-17A antibodies and uses thereof
|
|
CN111110841A
|
|
Stable formulations containing anti-PCSK 9 antibodies
|
|
CN110882385A
|
|
Use of anti-PD-1 antibodies in the treatment of tumors
|
|
CN110790837A
|
|
anti-BTLA antibodies
|
|
CN108456251A
|
|
Anti- PD-L1 antibody and its application
|
|
CN109071673A
|
|
Anti- PCSK9 antibody and its application
|
|
CN106390115A
|
|
Stable preparation of humanized monoclonal antibody
|
|
CN104250302A
|
|
Anti-PD-1 antibody and its application
|
